MedWatch

One actor accounts for a third of the market for painkillers

A new report shows that a single actor accounts for a third of the Danish market for pain medicines – a market that has shown very limited growth in 2011. The three largest companies account for almost 80 % of the market.

Foto: Esra Su / Stock.Xchng

In 2011 the Danish market for pain killers reached a total value of DKK 535 million, which constitutes a limited growth of 1 % since 2010.

According to the report “Analgesics in Denmark” from Euromonitor International, the company Nycomed accounts for 34.2 % of the total Danish market, which is expected to grow by 1 % yearly until 2016, at which time the total market value is expected to be DKK 550 million.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier